| Fast and slow parietal pathways mediate spatial attention CD Chambers, JM Payne, MG Stokes, JB Mattingley Nature neuroscience 7 (3), 217-218, 2004 | 293 | 2004 |
| Assessment of executive function and attention in children with neurofibromatosis type 1: relationships between cognitive measures and real-world behavior JM Payne, SL Hyman, EA Shores, KN North Child Neuropsychology 17 (4), 313-329, 2011 | 181 | 2011 |
| Disease Burden and Symptom Structure of Autism in Neurofibromatosis Type 1: A Study of the International NF1-ASD Consortium Team (INFACT) SM Morris, MT Acosta, S Garg, J Green, S Huson, E Legius, KN North, ... JAMA psychiatry 73 (12), 1276-1284, 2016 | 126 | 2016 |
| Brain structure and function in neurofibromatosis type 1: current concepts and future directions JM Payne, MD Moharir, R Webster, KN North Journal of Neurology, Neurosurgery & Psychiatry 81 (3), 304-309, 2010 | 120 | 2010 |
| Attentional load attenuates synaesthetic priming effects in grapheme-colour synaesthesia JB Mattingley, JM Payne, AN Rich Cortex 42 (2), 213-221, 2006 | 115 | 2006 |
| Randomized placebo-controlled study of lovastatin in children with neurofibromatosis type 1 JM Payne, B Barton, NJ Ullrich, A Cantor, SJC Hearps, G Cutter, T Rosser, ... Neurology 87 (24), 2575-2584, 2016 | 105 | 2016 |
| Corpus callosum morphology and its relationship to cognitive function in neurofibromatosis type 1 N Pride, JM Payne, R Webster, EA Shores, C Rae, KN North Journal of Child Neurology 25 (7), 834-841, 2010 | 94 | 2010 |
| The impact of ADHD on the cognitive and academic functioning of children with NF1 NA Pride, JM Payne, KN North Developmental neuropsychology 37 (7), 590-600, 2012 | 87 | 2012 |
| Social function and autism spectrum disorder in children and adults with neurofibromatosis type 1: a systematic review and meta-analysis AK Chisholm, VA Anderson, NA Pride, S Malarbi, KN North, JM Payne Neuropsychology Review 28, 317-340, 2018 | 74 | 2018 |
| Longitudinal assessment of cognition and T2‐hyperintensities in NF1: An 18‐year study JM Payne, T Pickering, M Porter, EC Oates, N Walia, K Prelog, KN North American Journal of Medical Genetics Part A 164 (3), 661-665, 2014 | 71 | 2014 |
| MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus PMK de Blank, AM Gross, S Akshintala, JO Blakeley, G Bollag, A Cannon, ... Neuro-oncology 24 (11), 1845-1856, 2022 | 70 | 2022 |
| Does attention‐deficit–hyperactivity disorder exacerbate executive dysfunction in children with neurofibromatosis type 1? JM Payne, SS Arnold, NA Pride, KN North Developmental Medicine & Child Neurology 54 (10), 898-904, 2012 | 70 | 2012 |
| Skeletal muscle and motor deficits in Neurofibromatosis Type 1 MA Summers, KG Quinlan, JM Payne, DG Little, KN North, A Schindeler J Musculoskelet Neuronal Interact 15 (2), 161-170, 2015 | 69 | 2015 |
| Parietal disruption impairs reflexive spatial attention within and between sensory modalities CD Chambers, JM Payne, JB Mattingley Neuropsychologia 45 (8), 1715-1724, 2007 | 63 | 2007 |
| Relationship between cognitive dysfunction, gait, and motor impairment in children and adolescents with neurofibromatosis type 1 JA Champion, KJ Rose, JM Payne, J Burns, KN North Developmental Medicine & Child Neurology 56 (5), 468-474, 2014 | 62 | 2014 |
| Social functioning in adults with neurofibromatosis type 1 NA Pride, H Crawford, JM Payne, KN North Research in developmental disabilities 34 (10), 3393-3399, 2013 | 56 | 2013 |
| The genetic and neuroanatomical basis of social dysfunction: lessons from neurofibromatosis type 1 NA Pride, MS Korgaonkar, B Barton, JM Payne, S Vucic, KN North Human brain mapping 35 (5), 2372-2382, 2014 | 51 | 2014 |
| Cognition, ADHD symptoms, and functional impairment in children and adolescents with neurofibromatosis type 1 JM Payne, KM Haebich, R MacKenzie, KS Walsh, SJC Hearps, D Coghill, ... Journal of attention disorders 25 (8), 1177-1186, 2021 | 50 | 2021 |
| Theory of mind in children with Neurofibromatosis Type 1. JM Payne, M Porter, NA Pride, KN North Neuropsychology 30 (4), 439, 2016 | 48 | 2016 |
| Young Australian adults with NF1 have poor access to health care, high complication rates, and limited disease knowledge EC Oates, JM Payne, SL Foster, NF Clarke, KN North American Journal of Medical Genetics Part A 161 (4), 659-666, 2013 | 38 | 2013 |